phase readout
saveNCT05726292: A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
RECRUITINGupdated 28m ago
community read0 votes
Sponsor: University of Chicago. Phase: PHASE2. Conditions: Prostate Cancer, Prostate Adenocarcinoma
view source ↗
comments(0)
5-min edit window · permanent after that